An interventional study of BATHE Therapeutic Interview Technique in Hypertension, sponsored by Dokuz Eylul University. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-08-13.
Sponsored by Dokuz Eylul University · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 128 studies in Hypertension with a site in Turkey — 21 open to participants now, 23 under way, 5 of them phase 3. Hypertension · Turkey.
Among the 128 studies in Hypertension with a site in Turkey, this one is the 49th largest by enrollment of the 93 interventional ones that give a count, is one of 5 that started in 2020, is one of 55 with no phase, and was the 125th registered.
6,120 studies on the registry are indexed under Hypertension; 913 are open to participants now.
Browse Hypertension studies →21 of the 128 studies in Hypertension with a site in Turkey are open now. Recruiting first, the newest first:
Hacettepe University · Sites in Turkey
Ages 18+ · Men only
Inonu University · Sites in Turkey
Ages 18+
Kutahya Health Sciences University · Sites in Turkey
Ages 18+ · Healthy volunteers
Hacettepe University · Sites in Turkey
Ages 40–75 · Healthy volunteers
Nadide Gizem Tarakci Filiz · Sites in Turkey
Ages 40–65
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 563 Hypertension studies recruiting now, 266 (47%) set no upper age limit and 200 (36%) stop at 75 or younger; 40 take children under 18; 139 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
128 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 3 · Phase 3 27 · Phase 4 9
First in 1998; this study’s year is marked. 5 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 86 is below the median of 100 across 4,579 interventional studies indexed under Hypertension.
Median enrollment 90 across the 93 interventional studies, 148 across the 35 observational. Of the 103 that completed or were terminated, 22 (21%) have results posted.
This tab as a report to print or save as PDF → With an account.
37 of 128 have an industry lead sponsor. The 10 most frequent:
Dokuz Eylul University is the lead sponsor of 261 studies on the registry; 35 are open to participants now.
Dokuz Eylul University has 2 studies filed under Hypertension — fewer than ten, so there is no comparison to draw.
7 of the studies in Hypertension with a site in Turkey that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03683186Phase 3United TherapeuticsA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | 2026-12 |
| NCT07890090Inonu UniversityTHE EFFECT OF EDUCATION IN PATIENTS WITH HYPERTENSION | 2026-12-01 |
| NCT07222917AstraZenecaA Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure. | 2026-12-10 |
| NCT07189637Nadide Gizem Tarakci FilizThe Combined Effect of the Mediterranean Diet and Intermittent Fasting on Hypertension | 2026-12-15 |
| NCT07747025Kutahya Health Sciences UniversityNurse-Led Motivational Interviewing for Blood Pressure Control | 2026-12-31 |
Add all 7 to your calendar (.ics) → With an account.
Among the 128 studies in Hypertension with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study evaluates the effect of the BATHE therapeutic interview technique on treatment adherence and blood pressure control in primary care hypertension patients.
Hypertension patients aged 18-80 years were randomly assigned to an intervention or control group. The intervention group received the structured BATHE communication technique during clinical visits, while the control group received standard primary care counseling on drug adherence and lifestyle changes. Patients were followed for 6 months (visits at baseline, 3 months, and 6 months). Primary outcomes assessed include treatment adherence scores, drug compliance, and blood pressure levels.
Study Design:
A single-blind, randomized controlled intervention trial conducted in a primary care setting.
Intervention \& Control:
All visits were conducted by a single physician.
Intervention Group: Received 5-7 minute BATHE technique consultations (Background, Affect, Troubling, Handling, Empathy) along with routine lifestyle and medication advice.
Control Group: Received routine primary care advice on medication adherence and lifestyle changes.
Follow-up \& Measurements:
Visits occurred at baseline (face-to-face), 3 months (online video), and 6 months (face-to-face).
Blood pressure, BMI, and waist circumference were measured at baseline and 6 months.
Treatment adherence and medication compliance scales were administered at baseline and 6 months.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Diagnosed with hypertension for at least 6 months
Aged between 18 and 80 years
Registered at the family health center where the study was conducted
Voluntary participation with signed
Ability to use online video communication channels (e.g., WhatsApp or another video interview channel)
Exclusion Criteria:
Presence of communication barriers
Active psychiatric disease or current use of psychiatric medication
Pregnancy
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants received 5-7 minute BATHE technique consultations (Background, Affect, Troubling, Handling, Empathy) at baseline, 3 months, and 6 months, alongside routine primary care counseling on drug adherence and lifestyle modifications.
Behavioral: BATHE Therapeutic Interview Technique
Participants received routine primary care counseling on drug adherence and lifestyle modifications routinely applied by the Department of Family Medicine at baseline, 3 months, and 6 months, without the BATHE technique.
A brief psychotherapeutic consultation tool consisting of 5 steps: Background, Affect, Troubling, Handling, and Empathy, applied during clinical visits to enhance treatment adherence and patient self-efficacy.
Change in Treatment Adherence Scores
Assessed using the Scale for Evaluating the Success of Treatment Compliance and Lifestyle Change in Hypertensive Individuals (18 items, total score ranging from 18 to 90, with scores \>= 68 indicating high treatment adherence).
Time frame: Baseline and 6th month
Plan to share: No
Ran from Oct 2020 to primary completion in Apr 2021, 6 months.
Of 1,405 non-industry interventional studies with no phase under Hypertension, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 6 months is below that.
Counting every sponsor, half of 1,500 studies reached it within 23 months; a quarter within 10 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.